To support this hypothesis, BCG-mediated trained immunity boosts the pro-inflammatory cytokine responses (99, 165), thereby resisting the infection towards other pathogens (99, 165)
High proportions reached clinically meaningful thresholds: up to 100% lost 5%, 93% lost 10%, and 83% lost 15% of body weight at higher doses
Patients with Parkinson's disease should not use GLP-1 receptor agonists outside of clinical trials or specific medical supervision for diabetes or obesity
Recommended monitoring protocol: Baseline: Full thyroid panel (TSH, free T4, free T3, TPO antibodies, thyroglobulin antibodies) plus thyroid ultrasound before starting GLP-1 therapy 6-8 weeks after starting GLP-1: Recheck TSH and free T4
Use a Travel-Sized Sharps Container Proper disposal of used pens or needles is not only a safety issue, it is also a legal one